Drug Controller General of India

Covid-19 Vaccine: Only 1 in 10 Take Jab After Four Weeks

According to data from the Ministry of Health, only about one in 10 or about 23,628 healthcare workers were inoculated with the second dose of the COVID-19 vaccine on February…

View Post

Covaxin Will Only Be Used As Backup Till The Completion Of Its Phase 3 Clinical Trials: AIIMS, ICMR Heads

The indigenous vaccine developed by Bharat Biotech with the Indian Council of Medical Research (ICMR) will be used as a “back-up” only if a large number of people need additional…

View Post

Efficacy, Price, Effectiveness: All You Need To Know About Covid-19 Vaccine’s Approved By India

India approved the use of two Covid-19 vaccines for emergency use on Sunday, launching one of the biggest world inoculation drives. India has approved the use of shots produced by both…

View Post

Two Covid-19 Vaccines Approved: From Factory To Syringe Everything You Need To Know

On Sunday (January 3), the Drug Controller General of India (DCGI), the national drug regulator of the country, announced that the Central Standard Drug Control Organization (CDSCO) had agreed to…

View Post

Serum Institute Submits Data For Emergency Approval Of Covishield

The Serum Institute of India (SII) has submitted additional data required by the Drug Controller General of India (DCGI) for determining the safety and immunogenicity of its Covid-19 vaccine candidate,…

View Post

COVAXIN Likely To Be Available For Public Use By February End

COVAXIN, the Covid vaccine candidate by Hyderabad-based vaccine manufacturer Bharat Biotech Limited, being developed in collaboration with the Indian Council of Medical Research (ICMR), is likely to be available for…

View Post

Covid-19 Detective Feluda: India’s Low-Cost Test Kit Detects Covid-19 In One Hour

The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test, powered by CSIR-IGIB (Institute of Genomics and Integrative Biology) FELUDA, received regulatory approvals today from the Drug Controller General of…

View Post

Menu

Drug Controller General of India

Covid-19 Vaccine: Only 1 in 10 Take Jab After Four Weeks

Covaxin Will Only Be Used As Backup Till The Completion Of Its Phase 3 Clinical Trials: AIIMS, ICMR Heads

Efficacy, Price, Effectiveness: All You Need To Know About Covid-19 Vaccine’s Approved By India

Two Covid-19 Vaccines Approved: From Factory To Syringe Everything You Need To Know

Serum Institute Submits Data For Emergency Approval Of Covishield

COVAXIN Likely To Be Available For Public Use By February End

Covid-19 Detective Feluda: India’s Low-Cost Test Kit Detects Covid-19 In One Hour

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns

Revolutionary CAR-T Cell Therapy Developed by AIIMS Researchers Offers New Hope for Multiple Myeloma Patients

Severe Strain of Bird Flu Spreading Rapidly: Is India at Risk of Another Pandemic?

India Achieves Significant Progress in Reducing Malaria Cases: WHO Report